Analyst Ratings for Banco Macro S.A. ADR (BMA)Updated: 2017-07-27
Banco Macro S.A. ADR (NYSE:BMA) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMA received an average rating of Overweight.
5 analysts declared BMA a buy, 0 gave an overweight rating, 6 issued a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Investment analysts gave a few price targets for BMA. The most optimistic analyst gave a price target of 142.46, which equates to a potential upside of 61.78 percent. The lowest price target was 85.16, implying a possible loss of -3.29 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
Analysts have revised their earnings estimates downwards for this quarter, by about -1.84 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 0.03 percent. Meanwhile, fiscal year estimates have been revised downwards by -0.62 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 0.2 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 2 analysts decreased their estimates.
BMA has an estimated earnings growth rate of 10.14 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of BMA is 1.11.
BMA has traded between a high of 97.86 and a low of 61.12 over the past year. The current market price is above the trailing year's low by 44.08 percent, and below the high by 10.01 percent. BMA has a P/E ratio of 11.3. Investors typically compare the P/E ratio to a company's peers in the industry. The BMA value stock report compares BMA to some of its peers using value stock charts. The market cap of BMA is $5.91 billion. BMA will post this quarters earnings in days, on 0000-00-00.